You are now leaving this website.
Are you sure?
NO
YES

HIGHLIGHTS

CORPORATE

A chat with Val Romberg

Kedrion Biopharma's new CEO shares his views

read more 

CORPORATE

Kedrion announces the appointment of a new CEO

Val Romberg from the USA, one of the most esteemed managers in the industry

read more 

CORPORATE

COVID-19. Kedrion partners with Columbia University Irving MC

Kedrion and Columbia University release video statements

read more 
  1. CORPORATE - 26-03-2018

    Human Rabies - An Interview with Peter J. Costa MPH

    Rabies Immune Globulin Brand Director at Kedrion Biopharma

    read more 
  2. CORPORATE - 12-02-2018

    Global Maternal Health Milestone Reached: 50th Anniversary

    U.S. Approval of RhoGAM®, Rho(D) Immune Globulin

    read more 
  3. EVENTS - 14-12-2017

    KEDRAB™: Pivotal Phase 2/3 Data presented at RITA Conference

    Kedrion Biopharma and Kamada Received FDA Approval of the Product in Q3 2017

    read more 
  4. CORPORATE - 25-08-2017

    Kedrion Biopharma and Kamada Receive FDA Approval of KEDRAB™

    For Post-Exposure Prophylaxis Against Rabies Infection

    read more 

Pages

For more information please contact: [email protected]